Mihaela Tevet
Bucharest, B, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 15, 2016
2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2, MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic Implications.
Journal: Maedica
Published: March 01, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.
Journal: British journal of haematology
Published: December 06, 2015
Multiple Intestinal Lymphoma.
Journal: Romanian journal of internal medicine = Revue roumaine de medecine interne
Published: June 17, 2015
CALR versus JAK2 mutated essential thrombocythaemia - a report on 141 patients.
Journal: British journal of haematology
Published: August 09, 2014
Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders.
Journal: Maedica
Published: November 15, 2013
Secondary Acute Lymphoblastic Leukemia after Hodgkin's Lymphoma or a Coincidental Association of Two Hematological Malignancies?
Journal: Maedica
Published: November 24, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026